Ohcanbohtosat - Laura Van't Veer
- Čájehuvvo 1 - 20 / 94
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature Dahkki Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer
Almmustuhtton 2010Artigo -
12
Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis Dahkki Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen
Almmustuhtton 2015Revisão -
13
-
14
-
15
Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer Dahkki Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes
Almmustuhtton 2004Artigo -
16
-
17
-
18
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients Dahkki James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer
Almmustuhtton 2017Artigo -
19
A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction Dahkki Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà
Almmustuhtton 2012Artigo -
20
Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes Dahkki Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer
Almmustuhtton 2013Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Cancer
Medicine
Breast cancer
Internal medicine
Oncology
Biology
Gene
Genetics
Cancer research
Gene expression
Biochemistry
Confidence interval
Bioinformatics
Computational biology
Hazard ratio
Chemotherapy
Mutation
Gene signature
Neoadjuvant therapy
Proportional hazards model
Pathology
Chemistry
Germline mutation
Gynecology
Paleontology
Computer science
Estrogen receptor
Environmental health
Gene expression profiling
Population